In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice


The success of Mycobacterium tuberculosis (Mtb) as a human pathogen relies on its ability to resist eradication by the immune system. The identification of mechanisms that enable Mtb to persist is key for finding ways to limit latent tuberculosis, which affects one-third of the world's population. Here we show that conditional gene silencing can be used to determine whether an Mtb gene required for optimal growth in vitro is also important for virulence and, if so, during which phase of an infection it is required. Application of this approach to the prcBA genes, which encode the core of the mycobacterial proteasome, revealed an unpredicted requirement of the core proteasome for the persistence of Mtb during the chronic phase of infection in mice. Proteasome depletion also attenuated Mtb in interferon-γ–deficient mice, pointing to a function of the proteasome beyond defense against the adaptive immune response. Genes that are essential for growth in vitro, in vivo or both account for approximately 20% of Mtb's genome. Conditional gene silencing could therefore facilitate the validation of up to 800 potential Mtb drug targets and improve our understanding of host-pathogen dynamics.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Tet-ON and Tet-OFF systems allow efficient and rapid silencing of proteasome expression.
Figure 2: In vitro phenotypes caused by prcBA silencing.
Figure 3: Induction of GFP expression in Mtb in mouse lungs.
Figure 4: The proteasome is essential for optimal growth and persistence of Mtb in mice.


  1. 1

    Corbett, E.L. et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163, 1009–1021 (2003).

    Article  Google Scholar 

  2. 2

    Gomez, J.E. & McKinney, J.D. M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb.) 84, 29–44 (2004).

    Article  Google Scholar 

  3. 3

    Sassetti, C.M., Boyd, D.H. & Rubin, E.J. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 48, 77–84 (2003).

    CAS  Article  Google Scholar 

  4. 4

    Sassetti, C.M. & Rubin, E.J. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. USA 100, 12989–12994 (2003).

    CAS  Article  Google Scholar 

  5. 5

    Ehrt, S. et al. Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor. Nucleic Acids Res. 33, e21 (2005).

    Article  Google Scholar 

  6. 6

    Ehrt, S. & Schnappinger, D. Controlling gene expression in mycobacteria. Future Microbiol. 1, 177–184 (2006).

    CAS  Article  Google Scholar 

  7. 7

    Guo, X.V. et al. Silencing essential protein secretion in Mycobacterium smegmatis using tetracycline repressors. J. Bacteriol. 189, 4614–4623 (2007).

    CAS  Article  Google Scholar 

  8. 8

    Chalut, C., Botella, L., de Sousa-D'Auria, C., Houssin, C. & Guilhot, C. The nonredundant roles of two 4′-phosphopantetheinyl transferases in vital processes of Mycobacteria. Proc. Natl. Acad. Sci. USA 103, 8511–8516 (2006).

    CAS  Article  Google Scholar 

  9. 9

    Hu, G. et al. Structure of the Mycobacterium tuberculosis proteasome and mechanism of inhibition by a peptidyl boronate. Mol. Microbiol. 59, 1417–1428 (2006).

    CAS  Article  Google Scholar 

  10. 10

    Lin, G. et al. Mycobacterium tuberculosis prcBA genes encode a gated proteasome with broad oligopeptide specificity. Mol. Microbiol. 59, 1405–1416 (2006).

    CAS  Article  Google Scholar 

  11. 11

    De Mot, R., Nagy, I., Walz, J. & Baumeister, W. Proteasomes and other self-compartmentalizing proteases in prokaryotes. Trends Microbiol. 7, 88–92 (1999).

    CAS  Article  Google Scholar 

  12. 12

    Knipfer, N. & Shrader, T.E. Inactivation of the 20S proteasome in Mycobacterium smegmatis. Mol. Microbiol. 25, 375–383 (1997).

    CAS  Article  Google Scholar 

  13. 13

    Nagy, I. et al. Characterization of a novel intracellular endopeptidase of the α/β hydrolase family from Streptomyces coelicolor A3(2). J. Bacteriol. 185, 496–503 (2003).

    CAS  Article  Google Scholar 

  14. 14

    Hong, B. et al. Inactivation of the 20S proteasome in Streptomyces lividans and its influence on the production of heterologous proteins. Microbiology 151, 3137–3145 (2005).

    CAS  Article  Google Scholar 

  15. 15

    Darwin, K.H., Ehrt, S., Gutierrez-Ramos, J.C., Weich, N. & Nathan, C.F. The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science 302, 1963–1966 (2003).

    CAS  Article  Google Scholar 

  16. 16

    Lamichhane, G. et al. Deletion of a Mycobacterium tuberculosis proteasomal ATPase homologue gene produces a slow-growing strain that persists in host tissues. J. Infect. Dis. 194, 1233–1240 (2006).

    CAS  Article  Google Scholar 

  17. 17

    Darwin, K.H., Lin, G., Chen, Z., Li, H. & Nathan, C.F. Characterization of a Mycobacterium tuberculosis proteasomal ATPase homologue. Mol. Microbiol. 55, 561–571 (2005).

    CAS  Article  Google Scholar 

  18. 18

    Pickart, C.M. & Cohen, R.E. Proteasomes and their kin: proteases in the machine age. Nat. Rev. Mol. Cell Biol. 5, 177–187 (2004).

    CAS  Article  Google Scholar 

  19. 19

    Festa, R.A., Pearce, M.J. & Darwin, K.H. Characterization of the proteasome accessory factor (paf) operon in Mycobacterium tuberculosis. J. Bacteriol. 189, 3044–3050 (2007).

    CAS  Article  Google Scholar 

  20. 20

    Berens, C. & Hillen, W. Gene regulation by tetracyclines. Constraints of resistance regulation in bacteria shape TetR for application in eukaryotes. Eur. J. Biochem. 270, 3109–3121 (2003).

    CAS  Article  Google Scholar 

  21. 21

    Ji, Y. et al. Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. Science 293, 2266–2269 (2001).

    CAS  Article  Google Scholar 

  22. 22

    Lathem, W.W., Price, P.A., Miller, V.L. & Goldman, W.E. A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science 315, 509–513 (2007).

    CAS  Article  Google Scholar 

  23. 23

    North, R.J. & Jung, Y.J. Immunity to tuberculosis. Annu. Rev. Immunol. 22, 599–623 (2004).

    CAS  Article  Google Scholar 

  24. 24

    Flynn, J.L. et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178, 2249–2254 (1993).

    CAS  Article  Google Scholar 

  25. 25

    De Mot, R., Schoofs, G. & Nagy, I. Proteome analysis of Streptomyces coelicolor mutants affected in the proteasome system reveals changes in stress-responsive proteins. Arch. Microbiol. 188, 257–271 (2007).

    CAS  Article  Google Scholar 

  26. 26

    Grune, T. et al. Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome. J. Biol. Chem. 273, 10857–10862 (1998).

    CAS  Article  Google Scholar 

  27. 27

    Munoz-Elias, E.J. et al. Replication dynamics of Mycobacterium tuberculosis in chronically infected mice. Infect. Immun. 73, 546–551 (2005).

    CAS  Article  Google Scholar 

  28. 28

    Demartino, G.N. & Gillette, T.G. Proteasomes: machines for all reasons. Cell 129, 659–662 (2007).

    CAS  Article  Google Scholar 

  29. 29

    Duncan, K. & Barry, C.E., III Prospects for new antitubercular drugs. Curr. Opin. Microbiol. 7, 460–465 (2004).

    CAS  Article  Google Scholar 

  30. 30

    Bardarov, S. et al. Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148, 3007–3017 (2002).

    CAS  Article  Google Scholar 

Download references


We thank G. Lin and C. Nathan (Weill Cornell Medical College) for PrcB-specific antiserum, R. Bryk and C. Nathan (Weill Cornell Medical College) for DlaT-specific antiserum and J. Cox (University of California, San Franciso) for plasmid pJSC284. Wild-type Mtb (H37Rv) was a gift from R. North (Trudeau Institute). We also thank L.M. Pierini for help with fluorescence microscopy, E. Hwang for technical support, C. Nathan and G. Lin for helpful discussions and K.H. Darwin and C. Nathan for reviewing the manuscript. This work was supported by the US National Institutes of Health (grant AI63446 to S.E.), the Irma T. Hirschl Trust (S.E.), the Ellison Medical Foundation (D.S.), the Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 473 (W.H.), the Fonds der Chemischen Industrie (W.H.) and the Bill and Melinda Gates Foundation and the Wellcome Trust through the Grand Challenges in Global Health Initiative (S.E., D.S.). The Department of Microbiology and Immunology acknowledges the support of the William Randolph Hearst Foundation.

Author information




S.G. performed experiments. D.S. guided experimental design and analyses. M.M. helped with initial experiments. W.H. provided constructs and advice. S.E. helped with experiments and guided the study. S.G., D.S. and S.E. wrote the paper. All authors discussed the results and commented on the manuscript.

Corresponding author

Correspondence to Sabine Ehrt.

Supplementary information

Supplementary Text and Figures

Supplementary Fig. 1 (PDF 138 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gandotra, S., Schnappinger, D., Monteleone, M. et al. In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice. Nat Med 13, 1515–1520 (2007).

Download citation

Further reading


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing